- Filed
- Mar 12, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Mar 7, 2025 | 142.15M sh |
| Long Term Debt | Q1 2025 · Feb 1, 2025 | $1.53B |
| Long Term Debt | Q1 2025 · Nov 2, 2024 | $1.53B |
| Short Term Debt | Q1 2025 · Feb 1, 2025 | $11.58M |
| Short Term Debt | Q1 2025 · Nov 2, 2024 | $11.7M |
| Short Term Investments | Q1 2025 · Feb 1, 2025 | $337.32M |
| Short Term Investments | Q1 2025 · Nov 2, 2024 | $316.34M |
| Cash And Equivalents | Q1 2025 · Feb 1, 2025 | $874.75M |
| Cash And Equivalents | Q1 2025 · Nov 2, 2024 | $934.86M |
| Current Liabilities | Q1 2025 · Feb 1, 2025 | $956.52M |
| Current Liabilities | Q1 2025 · Nov 2, 2024 | $999.84M |
| Total Liabilities | Q1 2025 · Feb 1, 2025 | $2.78B |
| Total Liabilities | Q1 2025 · Nov 2, 2024 | $2.83B |
| Current Assets | Q1 2025 · Feb 1, 2025 | $3.49B |
| Current Assets | Q1 2025 · Nov 2, 2024 | $3.54B |
| Total Assets | Q1 2025 · Feb 1, 2025 | $5.57B |
| Total Assets | Q1 2025 · Nov 2, 2024 | $5.64B |
| Shares Diluted | Q1 2025 · Jan 27, 2024 | 145.85M sh |
| Stock Repurchased | Q1 2025 · Jan 27, 2024 | $38.2M |
| Capex | Q1 2025 · Jan 27, 2024 | $16.6M |
| Operating Cash Flow | Q1 2025 · Jan 27, 2024 | $266.08M |
| Stockholders Equity | Q1 2025 · Jan 27, 2024 | $2.92B |
| Stockholders Equity | Q1 2025 · Oct 28, 2023 | $2.85B |
| Eps Diluted | Q1 2025 · Jan 27, 2024 | $0.34 |
| Eps Basic | Q1 2025 · Jan 27, 2024 | $0.34 |
| Sga Expense | Q1 2025 · Jan 27, 2024 | $54.68M |
| Rd Expense | Q1 2025 · Jan 27, 2024 | $187.27M |
| Net Income | Q1 2025 · Jan 27, 2024 | $49.55M |
| Operating Income | Q1 2025 · Jan 27, 2024 | $84.63M |
| Gross Profit | Q1 2025 · Jan 27, 2024 | $466.96M |
| Cost Of Revenue | Q1 2025 · Jan 27, 2024 | $570.75M |
| Revenue | Q1 2025 · Jan 27, 2024 | $1.04B |